Oxehealth: FDA Grants Oxehealth Vital Signs De Novo Clearance

Oxehealth Chief Executive Hugh Lloyd-Jukes said, "Receiving a de novo FDA clearance and creating an entirely new category of medical device is an exceptional achievement for Oxehealth.